Company name | Market Cap | Net Debt | Health score | Current ratio | Quick ratio | Net Debt to FCF | FCF to Interest | Intangibles as % of Total Assets | Total Debt to Equity |
$43.4B | ($3,739.4M) | 6.3 | 3.5x | 2.7x | (7.4x) | 18.1x | 7.4% | 7.4% | |
$242.4B | $7,054.0M | 6.8 | 1.7x | 1.2x | 1.1x | 16.0x | 8.2% | 31.4% | |
$154.5B | $10.7B | 5.9 | 1.1x | 0.5x | 4.4x | 8.0x | 17.0% | 50.7% | |
$150.5B | $7,786.0M | 5.3 | 1.9x | 1.1x | 2.2x | N/A | 0.0% | 28.4% | |
$120.9B | $25.4B | 6.3 | 1.9x | 0.6x | 4.6x | 7.2x | 13.5% | 53.6% | |
$34.9B | ($50.5M) | 6.5 | 1.5x | 1.2x | (0.1x) | 32.2x | 1.6% | 120.3% | |
$24.7B | €5,236.0M | 5.0 | 1.2x | 0.7x | 19.1x | 1.0x | 10.3% | 63.4% | |
$21.9B | ($30.2M) | 5.9 | 2.1x | 1.2x | (0.0x) | 7.1x | 19.2% | 1.9% | |
$21.6B | $5,679.1M | 6.5 | 2.9x | 1.3x | 5.0x | 7.3x | 21.5% | 43.0% | |
$19.4B | ($869.6M) | 6.4 | 3.6x | 2.5x | (2.9x) | 8.5x | 0.0% | 6.9% | |
$13.6B | ($955.7M) | 6.3 | 1.2x | 1.0x | (1.5x) | 146.5x | 1.7% | 2.3% |
The Edwards Lifesciences Corporation (EW) quick ratio is 2.7x, compared to the industry median of 2.3x and the 5-year historical average of 2.3x.
The Edwards Lifesciences Corporation (EW) net debt to FCF ratio is (7.4x), compared to the industry median of 0.4x and the 5-year historical average of ((1.4x)).
Edwards Lifesciences Corporation (EW) FCF to interest ratio is 18.1x, compared to the industry median of (5.7x) and the 5-year historical average of 118.2x.
The Edwards Lifesciences Corporation (EW) total debt to equity ratio is 7.4%, compared to the industry median of 17.5% and the 5-year historical average of 12.8%.